• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Snake venom is key ingredient in experimental drug for heart patients
An experimental antiplatelet drug has surprising bite. Based on a protein found in snake venom, the new drug prevented blood clotting in mice without causing excessive bleeding after an injury, according to research published Thursday in the journal Arteriosclerosis, Thrombosis and Vascular Biology. The drug has yet to be tested in humans.Bleeding is a common side effect in the current crop of available antiplatelet drugs, which are usually prescribed for heart patients to prevent blood cells, called platelets, from clumping together and forming clots. Depending on where they occur, clots can lead to a stroke or heart atta...
Source: Medical Hemostat - June 9, 2017 Category: Medical Devices Authors: hemostatguy at gmail.com (hemostat guy) Source Type: blogs

All Nurses Share the Same Struggles
Working in labor and delivery is everything you think it would be. It's sweet and inspiring. It's breathtakingly beautiful and miraculous. But OB is not all about babies and banners and bubblegum shaped like cigars. Labor and delivery can be heartbreaking. It can be so gut-wrenching that we sometimes leave work with our stomach in knots and our blood pressure pounding in our ears. Sometimes we leave work so angry our hands will shake the entire way home. Sometimes we leave work so unbelievably sad our whole body feels heavy and weighed with an emotional toll that can drag even the best obstetrical nurse down. But every day...
Source: Healthy Living - The Huffington Post - December 18, 2014 Category: Consumer Health News Source Type: news

Synthetic platelets helps clot blood faster
New York: Taking a cue from the human body’s own blood-clotting process, researchers at University of California, Santa Barbara have developed synthetic platelets that can do more than clot blood.By creating nanoparticles that mimic the shape, flexibility and surface biology of the body’s own platelets, the team was able to accelerate natural healing processes while opening the door to therapies and treatments that can be customised to specific patient needs.“This is a significant milestone in the development of synthetic platelets, as well as in targeted drug delivery,” said Samir Mitragotri, director of Center fo...
Source: Medical Hemostat - November 16, 2014 Category: Technology Consultants Authors: hemostatguy at gmail.com (hemostat guy) Source Type: blogs